Christopher Lemmon, Ph.D.
Massey Cancer Center research program membership
Cancer Cell Signaling
Department of Biomedical Engineering,
College of Engineering
MS, University of Wisconsin-Madison (2000)
PhD, Johns Hopkins University (2008)
My lab is interested in the field of mechanotherapeutics: therapies that target the structure of the desmoplastic extracellular matrix. My lab is particularly interested in disrupting assembly of the extracellular matrix protein fibronectin, which is assembled into viscoelastic fibrils in the matrix and plays a prominent role in promoting tumor growth and metastasis.
Disease focus of research
Biomarkers,Cancer cell biology,Cell signaling,Cytoskeleton,Metastasis,Signal transduction,Tumor microenvironment
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed